CV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) saw a large decrease in short interest during the month of January. As of January 15th, there was short interest totaling 14,803 shares, a decrease of 75.4% from the December 31st total of 60,091 shares. Based on an average trading volume of 1,035,303 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the stock are short sold. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 1,035,303 shares, the short-interest ratio is presently 0.0 days.
CV Sciences Trading Up 0.4%
Shares of CVSI opened at $0.04 on Friday. The company has a quick ratio of 0.21, a current ratio of 1.07 and a debt-to-equity ratio of 0.33. The firm’s fifty day simple moving average is $0.04 and its two-hundred day simple moving average is $0.04. CV Sciences has a 12 month low of $0.02 and a 12 month high of $0.10.
About CV Sciences
CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.
Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.
Featured Articles
- Five stocks we like better than CV Sciences
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
- Buy this Gold Stock Before May 2026
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- New Banking Law #1582 Could Unlock $21 Trillion for Americans
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
